当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
标题(英文)
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
条件
B-Cell Non-Hodgkin Lymphoma
干预
Biological: Anakinra|Biological: Axicabtagene Ciloleucel